Furosemide and acute kidney injury in neonates

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 93, Issue 4, 2008, Pages

  Moghal, N E ^a   Shenoy, M ^b  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; ANTIBIOTIC AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; GENTAMICIN; INDOMETACIN; LOOP DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; VANCOMYCIN;

BOLUS INJECTION; CAUSE OF DEATH; CONTINUOUS INFUSION; DRUG DOSE TITRATION; DRUG INDICATION; DRUG MECHANISM; ELECTROLYTE DISTURBANCE; ERYTHEMA MULTIFORME; GLOMERULUS FILTRATION RATE; HEART ARRHYTHMIA; HEMODYNAMICS; HIGH RISK POPULATION; HUMAN; HYPERCALCIURIA; HYPOKALEMIA; HYPONATREMIA; HYPOTENSION; KIDNEY INJURY; METABOLIC ALKALOSIS; NEPHROTOXICITY; NEWBORN; NEWBORN INTENSIVE CARE; OTOTOXICITY; PATHOPHYSIOLOGY; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; SKIN DISEASE;

DIURETICS; FUROSEMIDE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC;

EID: 47849117321     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2006.108860     Document Type: Review

References (36)

1. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med 1996;334:1448-60.
2. Moghal NE, Embleton ND. Management of acute renal failure in the newborn. Semin Fetal Neonatal Med 2006;11:207-13.
3. Agras PI, Tarcan A, Baskin E, et al. Acute renal failure in the neonatal period. Ren Fail 2004;26:305-9.
4. Stapleton FB, Jones DP, Green RS. Acute renal failure in neonates: incidence, etiology and outcome. Pediatr Nephrol 1987;1:314-20.
5. Cataldi L, Leone R, Moretti U, et al. Potential risk factors for the development of acute renal failure in preterm newborn infants: a case-control study. Ach Dis Child Fetal Neonatal Ed 2005;90:F514- 19.
6. Hentschel R, Lodige B, Bulla M. Renal insufficiency in the neonatal period. Clin Nephrol 1996;46:54-8.
7. Andreoli SP. Acute renal failure in the newborn. Semin Perinatol 2004;2:112-23.
8. Moghal NE, Brocklebank JT, Meadow SR. A review of acute renal failure in children: incidence, etiology and outcome. Clin Nephrol 1998;48:91-5.
9. Wilkins HW. Renal function in sick very low birthweight infants. 1. Glomerular filtration rate. Arch Dis Child 1992;67:1140-5.
10. Coulthard MG. Maturation of glomerular filtration in preterm and mature babies. Early Hum Dev 1985;11:281-92.
11. Vanpee M, Ergander U, Herin P, et al. Renal function in sick, very low-birth-weight infants. Acta Paediatr 1993;82:714-18.
12. Toth-Heyn P, Drukker A, Guignard JP. The stressed neonatal kidney: from pathophysiology to clinical management of neonatal vasomotor nephropathy. Pediatr Nephrol 2000;14:227-39.
13. Gaudio KM, Ardito TA, Reilly HF, et al. Accelerated cellular recoveryafter an ischemic renal injury. Am J Pathol 1983;112:338-46.
14. Siegel NJ, Van Why SK, Devarajan P. Pathogenesis of acute renal failure. In: Avner ED, Harmon WE, Niaudet P, eds. Textbook of pediatric nephrology. 5th edn. Lippincott: Williams & Wilkins, 2003:1223-32.
15. Brater DC. Clinical pharmacology of loop diuretics. Drugs 1991;41(Suppl 3):14-22.
16. Gerber JG, Nies AS. Furosemide induced vasodilatation: importance of state of hydration and filtration. Kidney Int 1980;18:454-9.
17. 2 production after furosemide administration. Hypertension 1988;11:491-4.
18. Shilliday IR, Quinn KJ, Allison ME. Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study. Nephrol Dial Transplant 1997;12:2592-6.
19. Cantarovich F, Rangoonwala B, Lorenz H. High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. Am J Kid Dis 2004;44:402-9.
20. Ho KM, Sheridan DJ. Meta-analysis of furosemide to prevent or treat acute renal failure. BMJ 2006;333:420.
21. Wilkins BH. Renal function in sick very low birthweight infants. 2. Urea and creatinine excretion. Arch Dis Child 1992;67:1146-53.
22. Giapros VI, Papaloukas AL, Andromkou AK. Urinary mineral excretion inpreterm neonates during first month of life. Neonatology 2007;91:180-5.
23. Knoben JE, Anderson PO, Knoben JE, et al. Handbook of clinical drug data. 6th edn. Hamilton, IL: Drug Intelligence Publications, 1988.
24. British National Formulary for children. London: BMJ Publishing Group, 2006.
25. Brater DC. In: van Boxtel CJ, Holford NHG, Danhof M, eds. Diuretic pharmacokinetics and pharmacodynamics. Amsterdam: Elsevier, 1992:253-75.
26. Prandota J. High doses of furosemide in children with acute renal failure. A preliminary retrospective study. Int Urol Nephrol 1991;23:383-92.
27. Mirochnick MH, Miceli JJ, Kramer PA, et al. Furosemide pharmacokinetics in very low birth weight infants. J Pediatr 1988;112:653-7.
28. Singh NC, Kissoon N, al Mofada S, et al. Comparison of continuous versus intermittent furosemide administration in post-operative pediatric cardiac patients. Crit Care Med 1992;20:17-21.
29. Luciani GB, Nichani S, Chang AC, et al. Continuous versus intermittent furosemide infusion incritically ill infants after open heart operations. Ann Thorac Surg 1997;64:1133-9.
30. Narendra A, White MP, Rolton HA, et al. Nephrocalcinosis in preterm babies. Arch Dis Child Fetal Neonatal Ed 2001;85:F207-13.
31. Rybak LP. Pathophysiology of furosemide ototoxicity. J Otolaryngol 1982;11:127-33.
32. Brion LP, Campbell DE. Furosemide in indomethacin-treated infants: systematic review and meta-analysis. Pediatr Nephrol 1999;13:212-18.
33. Moghal NE, Hegde S, Eastham KM. Ibuprofen and acute renal failure in a toddler. Arch Dis Child 2004;89:276-7.
34. Lawson DH, Tilstone WJ, Gray JM, et al. Effect of furosemide on the pharmacokinetics of gentamicin in patients. J Clin Pharmacol 1982;22:254-8.
35. Mancini ML, Dello Strologo L, Bianchi PM, et al. Sensorineural hearing loss in patients reaching chronic renal failure in childhood. Pediatr Nephrol 1996;10:38-40.
36. Robertson CM, Tyebkhan JM, Peliowski A, et al. Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure. Acta Paediatr 2006;95:214-23.